WallStreetZenWallStreetZen

NYSE: ZTS
Zoetis Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Zoetis revenue was $9.40B for the trailing 12 months ending Sep 30, 2025, with 11.4% growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $2.4B, down 2.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ZTS annual revenue was $9.3B, with 8.3% growth year-over-year.

ZTS past revenue growth

How has ZTS's revenue growth performed historically?

Company
2.68%
Industry
2.45%
Market
22.22%
ZTS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZTS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ZTS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ZTS revenue history

Current Revenue
$9.4B
Current Earnings
$2.7B
Current Profit Margin
28.2%
ZTS's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when ZTS announces revenue.

ZTS Revenue History By Year

ZTS Yearly RevenueZTS RevenueZTS ChangeZTS Revenue Growth
2024-12-31$9.26B$712.00M+8.33%
2023-12-31$8.54B$464.00M+5.74%
2022-12-31$8.08B$304.00M+3.91%
2021-12-31$7.78B$1.10B+16.49%
2020-12-31$6.68B$415.00M+6.63%
2019-12-31$6.26B$435.00M+7.47%
2018-12-31$5.83B$518.00M+9.76%
2017-12-31$5.31B$419.00M+8.57%
2016-12-31$4.89B$123.00M+2.58%
2015-12-31$4.77B-$20.00M-0.42%
2014-12-31$4.79B$224.00M+4.91%
2013-12-31$4.56B$225.00M+5.19%
2012-12-31$4.34B$103.00M+2.43%
2011-12-31$4.23B$651.00M+18.17%
2010-12-31$3.58B$822.00M+29.78%
2009-12-31$2.76BN/AN/A

1 of 2

Zoetis Revenue FAQ

What was ZTS's revenue last quarter?

On Invalid Date, Zoetis (NYSE: ZTS) reported Q3 2025 revenue of $2.40 billion up 0.5% year over year. In the same quarter last year, Zoetis's revenue was $2.39 billion.

What was Zoetis's revenue in 2024?

Zoetis's annual revenue for the twelve months ending Dec 31, 2024 was $9.26 billion, a 8.33% increase year over year.

How much does Zoetis make in a day?

Based on Zoetis annual revenue for the past five years, ZTS makes an average of $22,099,178.08 per day.

What was Zoetis's annual revenue growth in the past year?

As of Q4 2025, Zoetis's revenue has grown 2.68% year over year. This is 0.22 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 2.45%. Zoetis's revenue in the past year totaled $9.40 billion.

How much does Zoetis make in a year?

Zoetis's revenue by year for the past five years is:
  • Zoetis's revenue for the twelve months ending Dec 31, 2024 was $9.26 billion, a 8.33% increase year over year.
  • Zoetis's annual revenue for Dec 31, 2023 was $8.54 billion, a 5.74% increase from 2022.
  • Zoetis's annual revenue for 2022 was $8.08 billion, a 3.91% increase from 2021.
  • Zoetis's annual revenue for 2021 was $7.78 billion, a 16.49% increase from 2020.
  • Zoetis's annual revenue for 2020 was $6.68 billion, a 6.63% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.